Please assess the completion status of the following clinical trial:

Trial Title: Abdominal Nerve Blockade in Chronic Heart Failure.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of heart failure (HF)~* Symptomatic with dyspnea~* On a stable HF drug regimen~Exclusion Criteria:~* Ongoing treatment with oral anticoagulation other than aspirin~* Immunosuppressive medications for solid organ transplant~* Acute MI (STEMI or Type I NSTEMI) within 7 days~* Systolic blood pressure \< 90 mmHg or \>180 mmHg~* Infiltrative cardiomyopathy or constrictive cardiomyopathy~* Chronic kidney disease stage 5~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Regional nerve anesthesia (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).